GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Nuclear receptor ROR-alpha (Nuclear receptor RZR-alpha) (Nuclear receptor subfamily 1 group F member 1) (RAR-related orphan receptor A) (Retinoid-related orphan receptor-alpha)

 RORA_MOUSE              Reviewed;         523 AA.
P51448; P70283; P97741; P97773; Q923G1;
01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
01-OCT-1996, sequence version 1.
08-MAY-2019, entry version 186.
RecName: Full=Nuclear receptor ROR-alpha;
AltName: Full=Nuclear receptor RZR-alpha;
AltName: Full=Nuclear receptor subfamily 1 group F member 1;
AltName: Full=RAR-related orphan receptor A;
AltName: Full=Retinoid-related orphan receptor-alpha;
Name=Rora; Synonyms=Nr1f1, Rzra;
Mus musculus (Mouse).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Mus; Mus.
NCBI_TaxID=10090;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
STRAIN=C57BL/6J; TISSUE=Cerebellum;
PubMed=8602221; DOI=10.1038/379736a0;
Hamilton B.A., Frankel W.N., Kerrebrock A.W., Hawkins T.L.,
Fitzhugh W., Kusumi K., Russell L.B., Mueller K.L., Vanberkel V.,
Birren B.W., Kruglyak L., Lander E.S.;
"Disruption of the nuclear hormone receptor RORalpha in staggerer
mice.";
Nature 379:736-739(1996).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
STRAIN=C57BL/6J; TISSUE=Skin;
PubMed=7935491; DOI=10.1210/mend.8.6.7935491;
Carlberg C., Hooft van Huijsduijnen R., Staple J.K., Delamarter J.F.,
Becker-Andre M.;
"RZRs, a new family of retinoid-related orphan receptors that function
as both monomers and homodimers.";
Mol. Endocrinol. 8:757-770(1994).
[3]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND VARIANT SG
275-HIS--LYS-314 DEL.
STRAIN=C57BL/6J; TISSUE=Cerebellum;
PubMed=9226375; DOI=10.1006/geno.1997.4757;
Matysiak-Scholze U., Nehls M.C.;
"The structural integrity of ROR alpha isoforms is mutated in
staggerer mice: cerebellar coexpression of ROR alpha1 and ROR
alpha4.";
Genomics 43:78-84(1997).
[4]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
TISSUE=Brain;
PubMed=8750880; DOI=10.1016/0169-328X(95)00126-D;
Matsui T., Sashihara S., Oh Y., Waxman S.G.;
"An orphan nuclear receptor, mROR alpha, and its spatial expression in
adult mouse brain.";
Brain Res. Mol. Brain Res. 33:217-226(1995).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
STRAIN=FVB/N; TISSUE=Mammary gland;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[6]
PROTEIN SEQUENCE OF 39-61, AND IDENTIFICATION BY MASS SPECTROMETRY.
STRAIN=C57BL/6J; TISSUE=Brain;
Lubec G., Kang S.U.;
Submitted (APR-2007) to UniProtKB.
[7]
FUNCTION IN TRIGLYCERIDE METABOLISM, DNA-BINDING, AND CHARACTERIZATION
OF VARIANT SG PHENOTYPE.
PubMed=11053433; DOI=10.1074/jbc.M004982200;
Raspe E., Duez H., Gervois P., Fievet C., Fruchart J.C., Besnard S.,
Mariani J., Tedgui A., Staels B.;
"Transcriptional regulation of apolipoprotein C-III gene expression by
the orphan nuclear receptor RORalpha.";
J. Biol. Chem. 276:2865-2871(2001).
[8]
FUNCTION IN CEREBELLAR DEVELOPMENT, DEVELOPMENTAL STAGE, INTERACTION
WITH CTNNB1, AND CHARACTERIZATION OF VARIANT SG PHENOTYPE.
PubMed=14687547; DOI=10.1016/S0896-6273(03)00769-4;
Gold D.A., Baek S.H., Schork N.J., Rose D.W., Larsen D.D., Sachs B.D.,
Rosenfeld M.G., Hamilton B.A.;
"RORalpha coordinates reciprocal signaling in cerebellar development
through sonic hedgehog and calcium-dependent pathways.";
Neuron 40:1119-1131(2003).
[9]
FUNCTION IN CIRCADIAN RHYTHMS, AND CHARACTERIZATION OF VARIANT SG
PHENOTYPE.
PubMed=15821743; DOI=10.1038/nsmb925;
Akashi M., Takumi T.;
"The orphan nuclear receptor RORalpha regulates circadian
transcription of the mammalian core-clock Bmal1.";
Nat. Struct. Mol. Biol. 12:441-448(2005).
[10]
INTERACTION WITH PPARGC1A.
PubMed=17476214; DOI=10.1038/nature05767;
Liu C., Li S., Liu T., Borjigin J., Lin J.D.;
"Transcriptional coactivator PGC-1alpha integrates the mammalian clock
and energy metabolism.";
Nature 447:477-481(2007).
[11]
FUNCTION IN METABOLISM REGULATION, CHARACTERIZATION OF VARIANT SG
PHENOTYPE, AND TISSUE SPECIFICITY.
PubMed=17666523; DOI=10.1152/physiolgenomics.00098.2007;
Kang H.S., Angers M., Beak J.Y., Wu X., Gimble J.M., Wada T., Xie W.,
Collins J.B., Grissom S.F., Jetten A.M.;
"Gene expression profiling reveals a regulatory role for ROR alpha and
ROR gamma in phase I and phase II metabolism.";
Physiol. Genomics 31:281-294(2007).
[12]
FUNCTION IN METABOLISM REGULATION, CHARACTERIZATION OF VARIANT SG
PHENOTYPE, AND DNA-BINDING.
PubMed=18055760; DOI=10.1124/mol.107.040741;
Wada T., Kang H.S., Angers M., Gong H., Bhatia S., Khadem S., Ren S.,
Ellis E., Strom S.C., Jetten A.M., Xie W.;
"Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel
retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene
and a functional cross-talk between RORalpha and liver X receptor
(NR1H3).";
Mol. Pharmacol. 73:891-899(2008).
[13]
REVIEW OF FUNCTION IN METABOLISM REGULATION.
PubMed=18535165; DOI=10.3181/0802-MR-50;
Wada T., Kang H.S., Jetten A.M., Xie W.;
"The emerging role of nuclear receptor RORalpha and its crosstalk with
LXR in xeno- and endobiotic gene regulation.";
Exp. Biol. Med. 233:1191-1201(2008).
[14]
FUNCTION IN T(H)17 CELLS DIFFERENTIATION, INDUCTION BY IL6 AND TGFB1,
AND TISSUE SPECIFICITY.
PubMed=18164222; DOI=10.1016/j.immuni.2007.11.016;
Yang X.O., Pappu B.P., Nurieva R., Akimzhanov A., Kang H.S., Chung Y.,
Ma L., Shah B., Panopoulos A.D., Schluns K.S., Watowich S.S., Tian Q.,
Jetten A.M., Dong C.;
"T helper 17 lineage differentiation is programmed by orphan nuclear
receptors ROR alpha and ROR gamma.";
Immunity 28:29-39(2008).
[15]
FUNCTION IN LIPID METABOLISM REGULATION, TISSUE SPECIFICITY, AND
CHARACTERIZATION OF VARIANT SG PHENOTYPE.
PubMed=18441015; DOI=10.1074/jbc.M710526200;
Lau P., Fitzsimmons R.L., Raichur S., Wang S.C., Lechtken A.,
Muscat G.E.;
"The orphan nuclear receptor, RORalpha, regulates gene expression that
controls lipid metabolism: staggerer (SG/SG) mice are resistant to
diet-induced obesity.";
J. Biol. Chem. 283:18411-18421(2008).
[16]
INTERACTION WITH NCOA2.
PubMed=19039140; DOI=10.1126/science.1164847;
Chopra A.R., Louet J.F., Saha P., An J., Demayo F., Xu J., York B.,
Karpen S., Finegold M., Moore D., Chan L., Newgard C.B.,
O'Malley B.W.;
"Absence of the SRC-2 coactivator results in a glycogenopathy
resembling Von Gierke's disease.";
Science 322:1395-1399(2008).
[17]
FUNCTION, DEVELOPMENTAL STAGE, AND CHARACTERIZATION OF VARIANT SG.
PubMed=19014374; DOI=10.1111/j.1471-4159.2008.05739.x;
Fujieda H., Bremner R., Mears A.J., Sasaki H.;
"Retinoic acid receptor-related orphan receptor alpha regulates a
subset of cone genes during mouse retinal development.";
J. Neurochem. 108:91-101(2009).
[18]
FUNCTION IN ADIPOGENESIS, INTERACTION WITH CEBPB, AND DEVELOPMENTAL
STAGE.
PubMed=19324970; DOI=10.1210/me.2008-0277;
Ohoka N., Kato S., Takahashi Y., Hayashi H., Sato R.;
"The orphan nuclear receptor RORalpha restrains adipocyte
differentiation through a reduction of C/EBPbeta activity and
perilipin gene expression.";
Mol. Endocrinol. 23:759-771(2009).
[19]
REVIEW ON FUNCTION.
PubMed=19381306; DOI=10.1621/nrs.07003;
Jetten A.M.;
"Retinoid-related orphan receptors (RORs): critical roles in
development, immunity, circadian rhythm, and cellular metabolism.";
Nucl. Recept. Signal. 7:3-35(2009).
[20]
INTERACTION WITH MAGED1.
PubMed=20300063; DOI=10.1038/emboj.2010.34;
Wang X., Tang J., Xing L., Shi G., Ruan H., Gu X., Liu Z., Wu X.,
Gao X., Xu Y.;
"Interaction of MAGED1 with nuclear receptors affects circadian clock
function.";
EMBO J. 29:1389-1400(2010).
[21]
INTERACTION WITH PER2.
PubMed=20159955; DOI=10.1101/gad.564110;
Schmutz I., Ripperger J.A., Baeriswyl-Aebischer S., Albrecht U.;
"The mammalian clock component PERIOD2 coordinates circadian output by
interaction with nuclear receptors.";
Genes Dev. 24:345-357(2010).
[22]
FUNCTION IN GLUCOSE METABOLISM REGULATION, AND IDENTIFICATION OF
LIGANDS.
PubMed=19965867; DOI=10.1074/jbc.M109.080614;
Wang Y., Kumar N., Solt L.A., Richardson T.I., Helvering L.M.,
Crumbley C., Garcia-Ordonez R.D., Stayrook K.R., Zhang X., Novick S.,
Chalmers M.J., Griffin P.R., Burris T.P.;
"Modulation of retinoic acid receptor-related orphan receptor alpha
and gamma activity by 7-oxygenated sterol ligands.";
J. Biol. Chem. 285:5013-5025(2010).
[23]
FUNCTION, AND INTERACTION WITH NRIP1.
PubMed=21628546; DOI=10.1177/0748730411401579;
Poliandri A.H., Gamsby J.J., Christian M., Spinella M.J., Loros J.J.,
Dunlap J.C., Parker M.G.;
"Modulation of clock gene expression by the transcriptional
coregulator receptor interacting protein 140 (RIP140).";
J. Biol. Rhythms 26:187-199(2011).
[24]
FUNCTION IN T(H)17 CELLS DIFFERENTIATION, INDUCTION BY IL6 AND TGFB1,
INTERACTION WITH NCOR1 AND NCOA2, AND IDENTIFICATION OF LIGANDS.
PubMed=21499262; DOI=10.1038/nature10075;
Solt L.A., Kumar N., Nuhant P., Wang Y., Lauer J.L., Liu J.,
Istrate M.A., Kamenecka T.M., Roush W.R., Vidovic D., Schuerer S.C.,
Xu J., Wagoner G., Drew P.D., Griffin P.R., Burris T.P.;
"Suppression of TH17 differentiation and autoimmunity by a synthetic
ROR ligand.";
Nature 472:491-494(2011).
[25]
INTERACTION WITH CRY1.
PubMed=22170608; DOI=10.1038/nature10700;
Lamia K.A., Papp S.J., Yu R.T., Barish G.D., Uhlenhaut N.H.,
Jonker J.W., Downes M., Evans R.M.;
"Cryptochromes mediate rhythmic repression of the glucocorticoid
receptor.";
Nature 480:552-556(2011).
[26]
FUNCTION IN CIRCADIAN RHYTHMS, TISSUE SPECIFICITY, SUBCELLULAR
LOCATION, DNA-BINDING, AND INDUCTION.
PubMed=22753030; DOI=10.1093/nar/gks630;
Takeda Y., Jothi R., Birault V., Jetten A.M.;
"RORgamma directly regulates the circadian expression of clock genes
and downstream targets in vivo.";
Nucleic Acids Res. 40:8519-8535(2012).
[27]
REVIEW ON FUNCTION AND LIGANDS.
PubMed=22789990; DOI=10.1016/j.tem.2012.05.012;
Solt L.A., Burris T.P.;
"Action of RORs and their ligands in (patho)physiology.";
Trends Endocrinol. Metab. 23:619-627(2012).
[28]
FUNCTION, AND INDUCTION.
PubMed=23172836; DOI=10.1161/CIRCULATIONAHA.112.135608;
Saito T., Hirano M., Ide T., Ichiki T., Koibuchi N., Sunagawa K.,
Hirano K.;
"Pivotal role of Rho-associated kinase 2 in generating the intrinsic
circadian rhythm of vascular contractility.";
Circulation 127:104-114(2013).
[29]
FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PROX1.
PubMed=23723244; DOI=10.1093/nar/gkt447;
Takeda Y., Jetten A.M.;
"Prospero-related homeobox 1 (Prox1) functions as a novel modulator of
retinoic acid-related orphan receptors alpha- and gamma-mediated
transactivation.";
Nucleic Acids Res. 41:6992-7008(2013).
-!- FUNCTION: Nuclear receptor that binds DNA as a monomer to ROR
response elements (RORE) containing a single core motif half-site
5'-AGGTCA-3' preceded by a short A-T-rich sequence. Key regulator
of embryonic development, cellular differentiation, immunity,
circadian rhythm as well as lipid, steroid, xenobiotics and
glucose metabolism. Considered to have intrinsic transcriptional
activity, have some natural ligands like oxysterols that act as
agonists (25-hydroxycholesterol) or inverse agonists (7-oxygenated
sterols), enhancing or repressing the transcriptional activity,
respectively. Recruits distinct combinations of cofactors to
target genes regulatory regions to modulate their transcriptional
expression, depending on the tissue, time and promoter contexts.
Regulates genes involved in photoreceptor development including
OPN1SW, OPN1SM and ARR3 and skeletal muscle development with
MYOD1. Required for proper cerebellum development, regulates SHH
gene expression, among others, to induce granule cells
proliferation as well as expression of genes involved in calcium-
mediated signal transduction. Regulates the circadian expression
of several clock genes, including CLOCK, ARNTL/BMAL1, NPAS2 and
CRY1. Competes with NR1D1 for binding to their shared DNA response
element on some clock genes such as ARNTL/BMAL1, CRY1 and NR1D1
itself, resulting in NR1D1-mediated repression or RORA-mediated
activation of clock genes expression, leading to the circadian
pattern of clock genes expression. Therefore influences the period
length and stability of the clock. Regulates genes involved in
lipid metabolism such as apolipoproteins APOA1, APOA5, APOC3 and
PPARG. In liver, has specific and redundant functions with RORC as
positive or negative modulator of expression of genes encoding
phase I and phase II proteins involved in the metabolism of
lipids, steroids and xenobiotics, such as CYP7B1 and SULT2A1.
Induces a rhythmic expression of some of these genes. In addition,
interplays functionally with NR1H2 and NR1H3 for the regulation of
genes involved in cholesterol metabolism. Also involved in the
regulation of hepatic glucose metabolism through the modulation of
G6PC and PCK1. In adipose tissue, plays a role as negative
regulator of adipocyte differentiation, probably acting through
dual mechanisms. May suppress CEBPB-dependent adipogenesis through
direct interaction and PPARG-dependent adipogenesis through
competition for DNA-binding. Downstream of IL6 and TGFB and
synergistically with RORC isoform 2, is implicated in the lineage
specification of uncommitted CD4(+) T-helper (T(H)) cells into
T(H)17 cells, antagonizing the T(H)1 program. Probably regulates
IL17 and IL17F expression on T(H) by binding to the essential
enhancer conserved non-coding sequence 2 (CNS2) in the IL17-IL17F
locus. Involved in hypoxia signaling by interacting with and
activating the transcriptional activity of HIF1A. May inhibit cell
growth in response to cellular stress. May exert an anti-
inflammatory role by inducing CHUK expression and inhibiting NF-
kappa-B signaling. {ECO:0000269|PubMed:11053433,
ECO:0000269|PubMed:14687547, ECO:0000269|PubMed:15821743,
ECO:0000269|PubMed:17666523, ECO:0000269|PubMed:18055760,
ECO:0000269|PubMed:18164222, ECO:0000269|PubMed:18441015,
ECO:0000269|PubMed:19014374, ECO:0000269|PubMed:19324970,
ECO:0000269|PubMed:19965867, ECO:0000269|PubMed:21499262,
ECO:0000269|PubMed:21628546, ECO:0000269|PubMed:22753030,
ECO:0000269|PubMed:23172836, ECO:0000269|PubMed:23723244}.
-!- SUBUNIT: Monomer. Interacts (via the DNA-binding domain) with
HIF1A; the interaction enhances HIF1A transcription under hypoxia
through increasing protein stability. Interacts with CEBPB; the
interaction disrupts the interaction CEBPB:EP300. Interacts with
the coactivators NCOA2, PPARGC1A (via LXXLL motif), EP300 and
MED1. Interacts with the corepressor NCOR1. Interacts with MAGED1
and CTNNB1. Interacts with CRY1 and PER2. Interacts (via AF-2
motif) with PROX1. Interacts with NRIP1. Isoform 4 interacts (via
AF-2 motif) with isoform 1 of FOXP3 (via LXXLL motif) (By
similarity). {ECO:0000250|UniProtKB:P35398,
ECO:0000269|PubMed:14687547, ECO:0000269|PubMed:17476214,
ECO:0000269|PubMed:19039140, ECO:0000269|PubMed:19324970,
ECO:0000269|PubMed:20159955, ECO:0000269|PubMed:20300063,
ECO:0000269|PubMed:21499262, ECO:0000269|PubMed:21628546,
ECO:0000269|PubMed:22170608, ECO:0000269|PubMed:23723244}.
-!- INTERACTION:
P54254:Atxn1; NbExp=3; IntAct=EBI-1169722, EBI-1169713;
Q9QYH6:Maged1; NbExp=5; IntAct=EBI-1169722, EBI-1801274;
-!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
ProRule:PRU00407, ECO:0000269|PubMed:22753030,
ECO:0000269|PubMed:23723244}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative promoter usage; Named isoforms=4;
Name=1; Synonyms=Alpha-1;
IsoId=P51448-1; Sequence=Displayed;
Name=2; Synonyms=Alpha-2;
IsoId=P51448-3; Sequence=Not described;
Name=3; Synonyms=Alpha-3;
IsoId=P51448-4; Sequence=Not described;
Name=4; Synonyms=Alpha-4;
IsoId=P51448-2; Sequence=VSP_003658;
-!- TISSUE SPECIFICITY: Expressed in cerebellum, heart, liver, lung,
kidney, retina and brown and white adipose tissues. Expressed in
the subset of mature Th17 cells. {ECO:0000269|PubMed:17666523,
ECO:0000269|PubMed:18164222, ECO:0000269|PubMed:18441015,
ECO:0000269|PubMed:22753030}.
-!- DEVELOPMENTAL STAGE: In cerebellum, expression begins at 12.5 dpc.
In the developing retina, first expressed at 17 dpc in the
ganglion cell layer. At P3, expressed in the inner border of the
neuroblasitic border (presumptive amacrine cells). By P6, levels
increase in developing cones. Expression found in the presumptive
bipolar cells by P9. During adipocyte differentiation, expression
gradually increases. {ECO:0000269|PubMed:14687547,
ECO:0000269|PubMed:19014374, ECO:0000269|PubMed:19324970}.
-!- INDUCTION: In T(H) cells, induced upon antigen receptor ligation
in the presence of IL6 and TGB1 (via STAT3). Oscillates diurnally
in central nervous system. In liver, Isoform 1 oscillates
diurnally but not isoform 4. {ECO:0000269|PubMed:18164222,
ECO:0000269|PubMed:21499262, ECO:0000269|PubMed:22753030,
ECO:0000269|PubMed:23172836}.
-!- DOMAIN: The AF-2 (activation function-2) motif is required for
recruiting coregulators containing LXXLL motifs.
{ECO:0000250|UniProtKB:P35398}.
-!- PTM: Phosphorylation by conventional PKCs in neurons inhibits
transcriptional activity. Phosphorylated on Thr-183 by MAPK1/ERK1
in vitro. {ECO:0000250|UniProtKB:P35398}.
-!- PTM: Sumoylated by SENP1 and SENP2. Sumoylation, promoted by
PIAS2, PIAS3, PIAS4 but not PIAS1, enhances the transcriptional
activity. Desumoylated by SENP1. {ECO:0000250|UniProtKB:P35398}.
-!- PTM: Ubiquitinated, leading to its degradation by the proteasome.
Proteasomal degradation is required for efficient transcriptional
activity and is prevented by HR. {ECO:0000250|UniProtKB:P35398}.
-!- PTM: Isoform 1: monomethylated at Lys-38 by EZH2, this creates a
degron recognized by a DCX (DDB1-DCAF1/VPRBP-CUL4A-RBX1) E3
ubiquitin ligase complex. {ECO:0000250|UniProtKB:P35398}.
-!- DISEASE: Note=Defects in Rora are the cause of the staggerer (SG)
mutant phenotype which is characterized by disturbance of Purkinje
cell development and immune system functioning. This phenotype
exhibits lower body weight, reduced adiposity, decreased plasma
cholesterol, triglyceride and apolipoprotein CIII levels, and is
resistant to diet-induced obesity. Also has abnormal circadian
rhythms. {ECO:0000269|PubMed:11053433,
ECO:0000269|PubMed:14687547, ECO:0000269|PubMed:15821743,
ECO:0000269|PubMed:17666523, ECO:0000269|PubMed:18055760,
ECO:0000269|PubMed:18441015, ECO:0000269|PubMed:19014374,
ECO:0000269|PubMed:9226375}.
-!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
subfamily. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=AAH03757.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
Sequence=CAA69930.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; U53228; AAC52513.1; -; mRNA.
EMBL; Y08640; CAA69930.1; ALT_INIT; mRNA.
EMBL; Z82994; CAB05396.1; -; mRNA.
EMBL; S82720; AAB46801.2; -; mRNA.
EMBL; D45910; BAA22970.1; -; mRNA.
EMBL; BC003757; AAH03757.2; ALT_INIT; mRNA.
CCDS; CCDS23314.1; -. [P51448-1]
CCDS; CCDS72268.1; -. [P51448-2]
PIR; S68517; S68517.
RefSeq; NP_001276845.1; NM_001289916.1. [P51448-2]
RefSeq; NP_038674.1; NM_013646.2. [P51448-1]
SMR; P51448; -.
BioGrid; 202956; 1.
CORUM; P51448; -.
DIP; DIP-35351N; -.
IntAct; P51448; 3.
MINT; P51448; -.
STRING; 10090.ENSMUSP00000034766; -.
ChEMBL; CHEMBL3217403; -.
iPTMnet; P51448; -.
PhosphoSitePlus; P51448; -.
PaxDb; P51448; -.
PeptideAtlas; P51448; -.
PRIDE; P51448; -.
Ensembl; ENSMUST00000034766; ENSMUSP00000034766; ENSMUSG00000032238. [P51448-1]
Ensembl; ENSMUST00000113624; ENSMUSP00000109254; ENSMUSG00000032238. [P51448-2]
GeneID; 19883; -.
KEGG; mmu:19883; -.
UCSC; uc009qmx.2; mouse. [P51448-1]
CTD; 6095; -.
MGI; MGI:104661; Rora.
eggNOG; KOG4216; Eukaryota.
eggNOG; ENOG410XUGR; LUCA.
GeneTree; ENSGT00940000157387; -.
HOGENOM; HOG000010200; -.
InParanoid; P51448; -.
KO; K08532; -.
OMA; YQNKPRE; -.
OrthoDB; 583704at2759; -.
PhylomeDB; P51448; -.
TreeFam; TF319910; -.
Reactome; R-MMU-383280; Nuclear Receptor transcription pathway.
Reactome; R-MMU-4090294; SUMOylation of intracellular receptors.
ChiTaRS; Rora; mouse.
PRO; PR:P51448; -.
Proteomes; UP000000589; Chromosome 9.
Bgee; ENSMUSG00000032238; Expressed in 335 organ(s), highest expression level in medial geniculate body.
ExpressionAtlas; P51448; baseline and differential.
Genevisible; P51448; MM.
GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
GO; GO:0005634; C:nucleus; IDA:UniProtKB.
GO; GO:0008013; F:beta-catenin binding; IPI:UniProtKB.
GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:UniProtKB.
GO; GO:0098531; F:ligand-activated transcription factor activity; ISS:UniProtKB.
GO; GO:0004879; F:nuclear receptor activity; IEA:InterPro.
GO; GO:0008142; F:oxysterol binding; ISS:UniProtKB.
GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; ISO:MGI.
GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; ISO:MGI.
GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
GO; GO:0003707; F:steroid hormone receptor activity; IEA:InterPro.
GO; GO:0001223; F:transcription coactivator binding; IPI:UniProtKB.
GO; GO:0001222; F:transcription corepressor binding; ISO:MGI.
GO; GO:0008134; F:transcription factor binding; ISO:MGI.
GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
GO; GO:0001525; P:angiogenesis; ISS:UniProtKB.
GO; GO:0071456; P:cellular response to hypoxia; ISS:UniProtKB.
GO; GO:0071347; P:cellular response to interleukin-1; IDA:MGI.
GO; GO:0036315; P:cellular response to sterol; ISS:UniProtKB.
GO; GO:0071356; P:cellular response to tumor necrosis factor; IDA:MGI.
GO; GO:0021930; P:cerebellar granule cell precursor proliferation; IMP:UniProtKB.
GO; GO:0021702; P:cerebellar Purkinje cell differentiation; IMP:MGI.
GO; GO:0046068; P:cGMP metabolic process; IMP:MGI.
GO; GO:0042632; P:cholesterol homeostasis; IMP:UniProtKB.
GO; GO:0032922; P:circadian regulation of gene expression; IDA:UniProtKB.
GO; GO:0030522; P:intracellular receptor signaling pathway; ISS:UniProtKB.
GO; GO:0042692; P:muscle cell differentiation; ISS:UniProtKB.
GO; GO:0045599; P:negative regulation of fat cell differentiation; IMP:UniProtKB.
GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB.
GO; GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB.
GO; GO:0006809; P:nitric oxide biosynthetic process; IMP:MGI.
GO; GO:0042753; P:positive regulation of circadian rhythm; IDA:UniProtKB.
GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:MGI.
GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
GO; GO:0010575; P:positive regulation of vascular endothelial growth factor production; ISS:UniProtKB.
GO; GO:0042752; P:regulation of circadian rhythm; IMP:UniProtKB.
GO; GO:0010906; P:regulation of glucose metabolic process; IMP:UniProtKB.
GO; GO:0043030; P:regulation of macrophage activation; IMP:MGI.
GO; GO:0008589; P:regulation of smoothened signaling pathway; IMP:UniProtKB.
GO; GO:0019218; P:regulation of steroid metabolic process; IMP:UniProtKB.
GO; GO:0060850; P:regulation of transcription involved in cell fate commitment; IDA:UniProtKB.
GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
GO; GO:0072539; P:T-helper 17 cell differentiation; IMP:UniProtKB.
GO; GO:0070328; P:triglyceride homeostasis; IMP:UniProtKB.
GO; GO:0006805; P:xenobiotic metabolic process; IMP:UniProtKB.
Gene3D; 1.10.565.10; -; 1.
Gene3D; 3.30.50.10; -; 1.
InterPro; IPR035500; NHR-like_dom_sf.
InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
InterPro; IPR001723; Nuclear_hrmn_rcpt.
InterPro; IPR003079; ROR_rcpt.
InterPro; IPR001628; Znf_hrmn_rcpt.
InterPro; IPR013088; Znf_NHR/GATA.
Pfam; PF00104; Hormone_recep; 1.
Pfam; PF00105; zf-C4; 1.
PRINTS; PR01293; RORNUCRECPTR.
PRINTS; PR00398; STRDHORMONER.
PRINTS; PR00047; STROIDFINGER.
SMART; SM00430; HOLI; 1.
SMART; SM00399; ZnF_C4; 1.
SUPFAM; SSF48508; SSF48508; 1.
PROSITE; PS51843; NR_LBD; 1.
PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
1: Evidence at protein level;
Activator; Alternative promoter usage; Biological rhythms;
Complete proteome; Developmental protein; Direct protein sequencing;
Disease mutation; DNA-binding; Isopeptide bond; Metal-binding;
Methylation; Nucleus; Phosphoprotein; Receptor; Reference proteome;
Transcription; Transcription regulation; Ubl conjugation; Zinc;
Zinc-finger.
CHAIN 1 523 Nuclear receptor ROR-alpha.
/FTId=PRO_0000053513.
DOMAIN 272 510 NR LBD. {ECO:0000255|PROSITE-
ProRule:PRU01189}.
DNA_BIND 73 138 Nuclear receptor. {ECO:0000255|PROSITE-
ProRule:PRU00407}.
ZN_FING 73 93 NR C4-type. {ECO:0000255|PROSITE-
ProRule:PRU00407}.
ZN_FING 109 133 NR C4-type. {ECO:0000255|PROSITE-
ProRule:PRU00407}.
MOTIF 506 511 AF-2.
COMPBIAS 101 175 Gln-rich.
MOD_RES 38 38 N6-methyllysine.
{ECO:0000250|UniProtKB:P35398}.
MOD_RES 183 183 Phosphothreonine; by MAPK1.
{ECO:0000250|UniProtKB:P35398}.
CROSSLNK 240 240 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO).
{ECO:0000250}.
VAR_SEQ 1 66 MESAPAAPDPAASEPGSSGSEAAAGSRETPLTQDTGRKSEA
PGAGRRQSYASSSRGISVTKKTHTS -> MYFVIAAMKA
(in isoform 4).
{ECO:0000303|PubMed:15489334,
ECO:0000303|PubMed:7935491,
ECO:0000303|PubMed:8750880,
ECO:0000303|PubMed:9226375}.
/FTId=VSP_003658.
VARIANT 275 314 Missing (in SG; disturbance of Purkinje
cell and muscle development, lipid
metabolism, circadian behavior and immune
system functioning).
{ECO:0000269|PubMed:9226375}.
CONFLICT 163 163 H -> R (in Ref. 2; CAA69930).
{ECO:0000305}.
CONFLICT 180 181 EP -> T (in Ref. 2; CAA69930).
{ECO:0000305}.
CONFLICT 182 182 L -> I (in Ref. 4; AAB46801/BAA22970).
{ECO:0000305}.
CONFLICT 193 194 LT -> SA (in Ref. 2; CAA69930).
{ECO:0000305}.
CONFLICT 304 304 L -> W (in Ref. 2; CAA69930).
{ECO:0000305}.
CONFLICT 315 315 Missing (in Ref. 4; AAB46801/BAA22970).
{ECO:0000305}.
CONFLICT 362 362 E -> G (in Ref. 2; CAA69930).
{ECO:0000305}.
CONFLICT 433 433 R -> P (in Ref. 2; CAA69930).
{ECO:0000305}.
CONFLICT 450 451 QL -> HM (in Ref. 2; CAA69930).
{ECO:0000305}.
CONFLICT 487 487 K -> N (in Ref. 4; AAB46801/BAA22970).
{ECO:0000305}.
SEQUENCE 523 AA; 58845 MW; A194E02E4D9D177E CRC64;
MESAPAAPDP AASEPGSSGS EAAAGSRETP LTQDTGRKSE APGAGRRQSY ASSSRGISVT
KKTHTSQIEI IPCKICGDKS SGIHYGVITC EGCKGFFRRS QQSNATYSCP RQKNCLIDRT
SRNRCQHCRL QKCLAVGMSR DAVKFGRMSK KQRDSLYAEV QKHRMQQQQR DHQQQPGEAE
PLTPTYNISA NGLTELHDDL STYMDGHTPE GSKADSAVSS FYLDIQPSPD QSGLDINGIK
PEPICDYTPA SGFFPYCSFT NGETSPTVSM AELEHLAQNI SKSHLETCQY LREELQQITW
QTFLQEEIEN YQNKQREVMW QLCAIKITEA IQYVVEFAKR IDGFMELCQN DQIVLLKAGS
LEVVFIRMCR AFDSQNNTVY FDGKYASPDV FKSLGCEDFI SFVFEFGKSL CSMHLTEDEI
ALFSAFVLMS ADRSWLQEKV KIEKLQQKIQ LALQHVLQKN HREDGILTKL ICKVSTLRAL
CGRHTEKLMA FKAIYPDIVR LHFPPLYKEL FTSEFEPAMQ IDG


Related products :

Catalog number Product name Quantity
EIAAB35712 Homo sapiens,Human,NR1F1,Nuclear receptor ROR-alpha,Nuclear receptor RZR-alpha,Nuclear receptor subfamily 1 group F member 1,Retinoid-related orphan receptor-alpha,RORA,RZRA
EIAAB35713 Mouse,Mus musculus,Nr1f1,Nuclear receptor ROR-alpha,Nuclear receptor RZR-alpha,Nuclear receptor subfamily 1 group F member 1,Retinoid-related orphan receptor-alpha,Rora,Rzra
EIAAB35718 Mouse,Mus musculus,Nr1f3,Nuclear receptor ROR-gamma,Nuclear receptor RZR-gamma,Nuclear receptor subfamily 1 group F member 3,Retinoid-related orphan receptor-gamma,Rorc,Rorg,Thor,Thymus orphan recepto
EIAAB27815 Hzf-3,Nr4a2,Nuclear orphan receptor HZF-3,Nuclear receptor subfamily 4 group A member 2,Nurr1,NUR-related factor 1,Orphan nuclear receptor NURR1,Rat,Rattus norvegicus,Regenerating liver nuclear recept
EIAAB35717 Homo sapiens,Human,NR1F3,Nuclear receptor ROR-gamma,Nuclear receptor RZR-gamma,Nuclear receptor subfamily 1 group F member 3,Retinoid-related orphan receptor-gamma,RORC,RORG,RZRG
EIAAB35715 Homo sapiens,Human,NR1F2,Nuclear receptor ROR-beta,Nuclear receptor RZR-beta,Nuclear receptor subfamily 1 group F member 2,Retinoid-related orphan receptor-beta,RORB,RZRB
EIAAB35716 Nr1f2,Nuclear receptor ROR-beta,Nuclear receptor RZR-beta,Nuclear receptor subfamily 1 group F member 2,Rat,Rattus norvegicus,Retinoid-related orphan receptor-beta,Rorb,Rzrb
EIAAB35714 Mouse,Mus musculus,Nr1f2,Nuclear receptor ROR-beta,Nuclear receptor RZR-beta,Nuclear receptor subfamily 1 group F member 2,Retinoid-related orphan receptor-beta,Rorb
EIAAB27785 Homo sapiens,Human,NR1I2,Nuclear receptor subfamily 1 group I member 2,Orphan nuclear receptor PAR1,Orphan nuclear receptor PXR,Pregnane X receptor,PXR,Steroid and xenobiotic receptor,SXR
EIAAB27820 CHN,CSMF,Homo sapiens,Human,MINOR,Mitogen-induced nuclear orphan receptor,Neuron-derived orphan receptor 1,NOR1,NR4A3,Nuclear hormone receptor NOR-1,Nuclear receptor subfamily 4 group A member 3,TEC
EIAAB27812 Early response protein NAK1,GFRP1,HMR,Homo sapiens,Human,NAK1,NR4A1,Nuclear hormone receptor NUR_77,Nuclear receptor subfamily 4 group A member 1,Nur77,Orphan nuclear receptor HMR,Orphan nuclear recep
EIAAB27795 Mouse,Mtr2r1,Mus musculus,Nr2c2,Nuclear receptor subfamily 2 group C member 2,Orphan nuclear receptor TAK1,Orphan nuclear receptor TR4,Tak1,Testicular receptor 4,Tr4
EIAAB27794 Homo sapiens,Human,NR2C2,Nuclear receptor subfamily 2 group C member 2,Orphan nuclear receptor TAK1,Orphan nuclear receptor TR4,TAK1,Testicular receptor 4,TR4
EIAAB27778 EAR-1R,Homo sapiens,Human,NR1D2,Nuclear receptor subfamily 1 group D member 2,Orphan nuclear hormone receptor BD73,Rev-erb-beta,V-erbA-related protein 1-related
EIAAB27810 Gfrp,Hmr,Mouse,Mus musculus,N10,Nr4a1,Nuclear hormone receptor NUR_77,Nuclear protein N10,Nuclear receptor subfamily 4 group A member 1,Nur77,Orphan nuclear receptor HMR
20-372-60088 nuclear receptor subfamily 1. group H. member 3 (NR1H3). mRNA - Mouse monoclonal anti-human NR1H3 antibody; Liver X receptor alpha; Nuclear orphan receptor LXR-alpha Monoclonal 0.1 mg
EIAAB27782 Liver X receptor beta,Lxrb,Nr1h2,Nuclear receptor subfamily 1 group H member 2,Orphan nuclear receptor OR-1,Oxysterols receptor LXR-beta,Rat,Rattus norvegicus,Ubiquitously-expressed nuclear receptor,U
18-461-10220 Orphan nuclear receptor NR6A1 - Germ cell nuclear factor; GCNF; Retinoid receptor-related testis-specific receptor; RTR Polyclonal 0.05 ml
18-461-10165 Orphan nuclear receptor NR6A1 - Germ cell nuclear factor; GCNF; Retinoid receptor-related testis-specific receptor; RTR Polyclonal 0.05 ml
18-461-10219 Orphan nuclear receptor NR6A1 - Germ cell nuclear factor; GCNF; Retinoid receptor-related testis-specific receptor; RTR Polyclonal 0.05 ml
18-461-10218 Orphan nuclear receptor NR6A1 - Germ cell nuclear factor; GCNF; Retinoid receptor-related testis-specific receptor; RTR Polyclonal 0.05 ml
EIAAB27816 Mouse,Mus musculus,Nr4a2,Nuclear receptor subfamily 4 group A member 2,Nurr1,NUR-related factor 1,Orphan nuclear receptor NURR1
EIAAB27811 Canis familiaris,Canis lupus familiaris,Dog,HMR,NR4A1,Nuclear receptor subfamily 4 group A member 1,Orphan nuclear receptor HMR,Orphan nuclear receptor NGFI-B
EIAAB27790 Mouse,mTR2,Mus musculus,Nr2c1,Nuclear receptor subfamily 2 group C member 1,Orphan nuclear receptor TR2,Testicular receptor 2,Tr2,Tr2-11
EIAAB27793 Homo sapiens,Human,NR2C1,Nuclear receptor subfamily 2 group C member 1,Orphan nuclear receptor TR2,Testicular receptor 2,TR2
Pathways :
WP566: canonical wnt - zebrafish
WP1963: The effect of Glucocorticoids on target gene expression
WP2272: Pathogenic Escherichia coli infection
WP1112: EPO Receptor Signaling
WP313: Signaling of Hepatocyte Growth Factor Receptor
WP783: Androgen Receptor Signaling Pathway
WP1249: EPO Receptor Signaling
WP2328: Allograft rejection
WP57: Signal Transduction of S1P Receptor
WP927: Signaling of Hepatocyte Growth Factor Receptor
WP1309: Toll-like receptor signaling pathway
WP949: Toll-like receptor signaling pathway
WP1130: T Cell Receptor Signaling Pathway
WP1449: Regulation of toll-like receptor signaling pathway
WP352: T Cell Receptor Signaling Pathway
WP810: Signaling of Hepatocyte Growth Factor Receptor
WP2140: MaxYvesSuperCombo
WP407: Kit Receptor Signaling Pathway
WP1004: Kit Receptor Signaling Pathway
WP258: TGF-beta Receptor Signaling Pathway
WP996: EPO Receptor Signaling
WP1161: TGF-beta Receptor Signaling Pathway
WP734: Serotonin Receptor 4/6/7 and NR3C Signaling
WP1183: Toll-like receptor signaling pathway
WP444: Signaling of Hepatocyte Growth Factor Receptor

Related Genes :
[RORA NR1F1 RZRA] Nuclear receptor ROR-alpha (Nuclear receptor RZR-alpha) (Nuclear receptor subfamily 1 group F member 1) (RAR-related orphan receptor A) (Retinoid-related orphan receptor-alpha)
[Rora Nr1f1 Rzra] Nuclear receptor ROR-alpha (Nuclear receptor RZR-alpha) (Nuclear receptor subfamily 1 group F member 1) (RAR-related orphan receptor A) (Retinoid-related orphan receptor-alpha)
[RORC NR1F3 RORG RZRG] Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma)
[Rorc Nr1f3 Rorg Thor] Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR)
[NR1D2] Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R)
[NR4A1 GFRP1 HMR NAK1] Nuclear receptor subfamily 4 group A member 1 (Early response protein NAK1) (Nuclear hormone receptor NUR/77) (Nur77) (Orphan nuclear receptor HMR) (Orphan nuclear receptor TR3) (ST-59) (Testicular receptor 3)
[Nr2c2 Mtr2r1 Tak1 Tr4] Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4)
[NR2C2 TAK1 TR4] Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4)
[RORC NR1F3] Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (Retinoid-related orphan receptor-gamma)
[RXRA NR2B1] Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha)
[THRA EAR7 ERBA1 NR1A1 THRA1 THRA2] Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1) (V-erbA-related protein 7) (EAR-7) (c-erbA-1) (c-erbA-alpha)
[RARA NR1B1] Retinoic acid receptor alpha (RAR-alpha) (Nuclear receptor subfamily 1 group B member 1)
[ESRRA ERR1 ESRL1 NR3B1] Steroid hormone receptor ERR1 (Estrogen receptor-like 1) (Estrogen-related receptor alpha) (ERR-alpha) (Nuclear receptor subfamily 3 group B member 1)
[Esrra Err1 Estrra Nr3b1] Steroid hormone receptor ERR1 (Estrogen receptor-like 1) (Estrogen-related receptor alpha) (ERR-alpha) (Nuclear receptor subfamily 3 group B member 1)
[NR1D1 EAR1 HREV THRAL] Nuclear receptor subfamily 1 group D member 1 (Rev-erbA-alpha) (V-erbA-related protein 1) (EAR-1)
[Rxra Nr2b1] Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha)
[Nr2c1 Tr2 Tr2-11] Nuclear receptor subfamily 2 group C member 1 (Orphan nuclear receptor TR2) (Testicular receptor 2) (mTR2)
[Nr1d2] Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear receptor RVR) (Rev-erb-beta)
[raraa nr1b1a rara2a zgc:109797] Retinoic acid receptor alpha-A (RAR-alpha-A) (Nuclear receptor subfamily 1 group B member 1-A) (Retinoic acid receptor alpha) (zRAR alpha) (Retinoic acid receptor alpha-2.A) (RAR-alpha-2.A)
[Nr4a1 Gfrp Hmr N10 Nur77] Nuclear receptor subfamily 4 group A member 1 (Nuclear hormone receptor NUR/77) (Nuclear protein N10) (Orphan nuclear receptor HMR)
[rxrga nr2b1 nr2b3a rxr rxra rxrg] Retinoic acid receptor RXR-gamma-A (Nuclear receptor subfamily 2 group B member 3-A) (Retinoic acid receptor RXR-alpha) (Retinoid X receptor alpha) (Retinoid X receptor gamma-A)
[Nr1h2 Lxrb] Oxysterols receptor LXR-beta (Liver X receptor beta) (Nuclear receptor subfamily 1 group H member 2) (Orphan nuclear receptor OR-1) (Ubiquitously-expressed nuclear receptor) (UR)
[Nr4a1 Hmr Ngfib] Nuclear receptor subfamily 4 group A member 1 (NUR77) (Nerve growth factor-induced protein I-B) (NGFI-B) (Orphan nuclear receptor HMR)
[Rxra Nr2b1] Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha)
[Nr1d1 Ear1] Nuclear receptor subfamily 1 group D member 1 (Rev-erbA-alpha) (V-erbA-related protein 1) (EAR-1)
[rarab nr1b1b rara2b] Retinoic acid receptor alpha-B (RAR-alpha-B) (Nuclear receptor subfamily 1 group B member 1-B) (Retinoic acid receptor alpha-2.B) (RAR-alpha-2.B)
[ESR1 ESR NR3A1] Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1)
[NR1H4 BAR FXR HRR1 RIP14] Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14)
[NR5A2 B1F CPF FTF] Nuclear receptor subfamily 5 group A member 2 (Alpha-1-fetoprotein transcription factor) (B1-binding factor) (hB1F) (CYP7A promoter-binding factor) (Hepatocytic transcription factor) (Liver receptor homolog 1) (LRH-1)
[Rara Nr1b1] Retinoic acid receptor alpha (RAR-alpha) (Nuclear receptor subfamily 1 group B member 1)

Bibliography :
[31017814] The effects of extremely low-frequency electromagnetic fields on c-Maf, STAT6, and RORα expressions in spleen and thymus of rat.
[31012003] Molecular Mechanisms of Control of Differentiation of Regulatory T-Lymphocytes by Exogenous Melatonin.
[30987323] N-Terminal Domain Mediated Regulation of RORα1 Inhibits Invasive Growth in Prostate Cancer.
[30728500] The CH25H-CYP7B1-RORα axis of cholesterol metabolism regulates osteoarthritis.
[30704168] [IL-25-regulated type 2 innate lymphoid cells activation promote allergic fungal rhinosinusitis].
[30485323] RORα controls inflammatory state of human macrophages.
[30366765] T-Cell-Intrinsic Receptor Interacting Protein 2 Regulates Pathogenic T Helper 17 Cell Differentiation.
[30189901] The role of RORα in salivary gland lesions in patients with primary Sjögren's syndrome.
[30125682] 1800 MHz radiofrequency fields inhibits testosterone production via CaMKI /RORα pathway.
[30093563] miR-652 Promotes Tumor Proliferation and Metastasis by Targeting in Endometrial Cancer.